Product Information

BUDESONIDE EC 3 MG CAPSULE is a generic product labeled by Mayne Pharma, priced at $0.5154 per EA under NDC 51862058001. Its NADAC has been published 321 times since Feb 12, 2020.

FDA first approved this application on Apr 8, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BUDESONIDE EC 3 MG CAPSULE

Budesonide
$0.5154per EA

Strength

3 mg/1

Manufacturer

Mayne Pharma

NDC

51862058001

Classification

Generic

Dosage Form

CAPSULE, DELAYED RELEASE PELLETS

Route

ORAL

Effective Date

3/18/2026

Active Ingredients

BUDESONIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA206623

FDA Approved

4/8/2016

TE Code

AB

On Market Since

10/31/2019

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for BUDESONIDE EC 3 MG CAPSULE has been published 321 times since Feb 12, 2020, and over the history we have for it it has declined 70.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5154 per EA
All-time high$1.8078 (Apr 15, 2020)
All-time low$0.4242 (Nov 20, 2024)
52-week high$0.5221
52-week low$0.5024
Median price$0.6829
Average price$0.7841
Largest weekly change-35.6% (Apr 22, 2020)
Weeks tracked321
Tracking sinceFeb 12, 2020

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

+1.5%

3Y

-20.5%

5Y

-42.0%

All

-70.8%

Last surveyed Apr 1, 2026 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BUDESONIDE EC 3 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for BUDESONIDE EC 3 MG CAPSULE, manufactured by Mayne Pharma, is $0.5154 per EA (NDC 51862058001), effective Apr 1, 2026.

How has the price of BUDESONIDE EC 3 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for BUDESONIDE EC 3 MG CAPSULE has declined 70.8%. It has been tracked across 321 weekly CMS publications since Feb 12, 2020.

What are the highest and lowest recorded NADAC prices for BUDESONIDE EC 3 MG CAPSULE?

Since Feb 12, 2020, the NADAC for BUDESONIDE EC 3 MG CAPSULE has ranged from a low of $0.4242 (Nov 20, 2024) to a high of $1.8078 (Apr 15, 2020), with a median of $0.6829 per EA.

Are there cheaper alternatives to BUDESONIDE EC 3 MG CAPSULE?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUDESONIDE EC 3 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures BUDESONIDE EC 3 MG CAPSULE?

BUDESONIDE EC 3 MG CAPSULE (NDC 51862058001) is labeled by Mayne Pharma, and CMS classifies it as a generic product.